International Journal of Cancer Management

Published by: Kowsar

Does a Single Dose of Adenosine in Epidural Space Reduce Cancer-Related Neuropathic Pain? A Randomized Clinical Trial

Farid Abolhasan Gharehdaghi 1 , Ehsan Shahverdi 2 , 3 , Naghmeh Niktoreh Mofrad 3 , Mohammad Faranoush 4 , * and Abbas Ebadi 5
Authors Information
1 Pain Department, Mahak’s Pediatric Cancer Treatment and Research Center, Tehran, IR Iran
2 Blood Transfusion Research Center, High Institute for Research and Education in Transfusion Medicine, Tehran, IR Iran
3 Blood and Cancer Research Center, Mahak’s Pediatric Cancer Treatment and Research Center, Tehran, IR Iran
4 Pediatric Growth and Development Research Center, Institute of Endocrinology and Metabolism, Iran University of Medical Sciences, Tehran, IR Iran
5 Baqiyatallah University of Medical Sciences, Tehran, IR Iran
Article information
  • International Journal of Cancer Management: May 2018, 11 (5); e61872
  • Published Online: May 12, 2018
  • Article Type: Research Article
  • Received: September 22, 2017
  • Revised: January 1, 2018
  • Accepted: January 10, 2018
  • DOI: 10.5812/ijcm.61872

To Cite: Abolhasan Gharehdaghi F, Shahverdi E, Niktoreh Mofrad N, Faranoush M, Ebadi A. et al. Does a Single Dose of Adenosine in Epidural Space Reduce Cancer-Related Neuropathic Pain? A Randomized Clinical Trial, Int J Cancer Manag. 2018 ; 11(5):e61872. doi: 10.5812/ijcm.61872.

Abstract
Copyright © 2018, Cancer Research Center (CRC), Shahid Beheshti University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited
1. Background
2. Methods
3. Results
4. Discussion
Acknowledgements
Footnotes
References
  • 1. Zhang C, Zhang J, Wang G, Xu J, Li Y, Guo Q, et al. Benefit of Sunitinib in the treatment of pulmonary primitive neuroectodermal tumors: a case report and literature review. Oncotarget. 2016;7(52):87543-51. doi: 10.18632/oncotarget.13896. [PubMed: 27974690]. [PubMed Central: PMC5350009].
  • 2. Thönnes S, Sorg H, Hauser J, Tilkorn DJ. Localized eosinophilic fasciitis (Shulman’s disease) as a differential diagnosis of nerve compression syndrome. InnovatSurg Sci. 2017;2(1):23-5. doi: 10.1515/iss-2016-0203.
  • 3. Jensen TS, Gottrup H, Sindrup SH, Bach FW. The clinical picture of neuropathic pain. Eur J Pharmacol. 2001;429(1-3):1-11. [PubMed: 11698022].
  • 4. Raphael J, Hester J, Ahmedzai S, Barrie J, Farqhuar-Smith P, Williams J, et al. Cancer pain: part 2: physical, interventional and complimentary therapies; management in the community; acute, treatment-related and complex cancer pain: a perspective from the British Pain Society endorsed by the UK Association of Palliative Medicine and the Royal College of General Practitioners. Pain Med. 2010;11(6):872-96. doi: 10.1111/j.1526-4637.2010.00841.x. [PubMed: 20456069].
  • 5. World Health Organization. WHO's cancer pain ladder for adults. 2014.
  • 6. Johansson B, Halldner L, Dunwiddie TV, Masino SA, Poelchen W, Gimenez-Llort L, et al. Hyperalgesia, anxiety, and decreased hypoxic neuroprotection in mice lacking the adenosine A1 receptor. Proc Natl Acad Sci U S A. 2001;98(16):9407-12. doi: 10.1073/pnas.161292398. [PubMed: 11470917]. [PubMed Central: PMC55434].
  • 7. Durante M, Squillace S, Stockstill K, Wahlman C, Masini E, Tosh D, et al. (193) Contribution of IL-10 and T cells in beneficial effects exerted by A 3 adenosine receptor agonists in blocking and reversing neuropathic pain. J Pain. 2017;18(4). S24. doi: 10.1016/j.jpain.2017.02.100.
  • 8. Nascimento FP, Macedo Jr SJ, Santos AR. The involvement of purinergic system in pain: adenosine receptors and inosine as pharmacological tools in future treatments. InTech; 2012.
  • 9. Jin X, Mi W. Adenosine for postoperative analgesia: A systematic review and meta-analysis. PLoS One. 2017;12(3). e0173518. doi: 10.1371/journal.pone.0173518. [PubMed: 28333936]. [PubMed Central: PMC5363816].
  • 10. Eisenach JC, Rauck RL, Curry R. Intrathecal, but not intravenous adenosine reduces allodynia in patients with neuropathic pain. Pain. 2003;105(1-2):65-70. [PubMed: 14499421].
  • 11. Zhang Y, Conklin DR, Li X, Eisenach JC. Intrathecal morphine reduces allodynia after peripheral nerve injury in rats via activation of a spinal A1 adenosine receptor. Anesthesiology. 2005;102(2):416-20. [PubMed: 15681960].
  • 12. Kliger M, Stahl S, Haddad M, Suzan E, Adler R, Eisenberg E. Measuring the Intensity of Chronic Pain: Are the Visual Analogue Scale and the Verbal Rating Scale Interchangeable? Pain Pract. 2015;15(6):538-47. doi: 10.1111/papr.12216. [PubMed: 24735056].
  • 13. Lee JJ, Lee MK, Kim JE, Kim HZ, Park SH, Tae JH, et al. Pain relief scale is more highly correlated with numerical rating scale than with visual analogue scale in chronic pain patients. Pain Physician. 2015;18(2):E195-200. [PubMed: 25794219].
  • 14. Boonstra AM, Schiphorst Preuper HR, Balk GA, Stewart RE. Cut-off points for mild, moderate, and severe pain on the visual analogue scale for pain in patients with chronic musculoskeletal pain. Pain. 2014;155(12):2545-50. doi: 10.1016/j.pain.2014.09.014. [PubMed: 25239073].
  • 15. Hayashida M, Fukuda K, Fukunaga A. Clinical application of adenosine and ATP for pain control. J Anesth. 2005;19(3):225-35. doi: 10.1007/s00540-005-0310-8. [PubMed: 16032451].
  • 16. Ablin JN, Buskila D. "Real-life" treatment of chronic pain: Targets and goals. Best Pract Res Clin Rheumatol. 2015;29(1):111-9. doi: 10.1016/j.berh.2015.04.020. [PubMed: 26267005].
  • 17. Gilron I, Baron R, Jensen T. Neuropathic pain: principles of diagnosis and treatment. Mayo Clinic Proceedings. Elsevier; 2015.
  • 18. Afsharimani B, Kindl K, Good P, Hardy J. Pharmacological options for the management of refractory cancer pain-what is the evidence? Support Care Cancer. 2015;23(5):1473-81. doi: 10.1007/s00520-015-2678-9. [PubMed: 25749509].
  • 19. Schug SA, Chandrasena C. Pain management of the cancer patient. Expert Opin Pharmacother. 2015;16(1):5-15. doi: 10.1517/14656566.2015.980723. [PubMed: 25479712].
  • 20. Thompson SM, Haas HL, Gahwiler BH. Comparison of the actions of adenosine at pre- and postsynaptic receptors in the rat hippocampus in vitro. J Physiol. 1992;451:347-63. [PubMed: 1403815]. [PubMed Central: PMC1176165].
  • 21. Belfrage M, Sollevi A, Segerdahl M, Sjolund KF, Hansson P. Systemic adenosine infusion alleviates spontaneous and stimulus evoked pain in patients with peripheral neuropathic pain. Anesth Analg. 1995;81(4):713-7. [PubMed: 7573999].
  • 22. Belfrage M, Segerdahl M, Arner S, Sollevi A. The safety and efficacy of intrathecal adenosine in patients with chronic neuropathic pain. Anesth Analg. 1999;89(1):136-42. [PubMed: 10389791].
  • 23. Sawynok J. Adenosine and ATP receptors. Analgesia. Springer; 2006.
  • 24. Fyneface-Ogan S. Anatomy and clinical importance of the epidural space. Epidural Analgesia-Current Views and Approaches. InTech; 2012.
  • 25. Gharehdaghi A, Tashvighi M, Mehrvar A. Analgesic Effect of a Single Dose of Adenosine for Neuropathic Pain Reduction in a Patient with Primitive Neuroechtodermal Tumor. IJBC. 2011;6(4):215-9.
  • 26. Yamaoka G, Horiuchi H, Morino T, Miura H, Ogata T. Different analgesic effects of adenosine between postoperative and neuropathic pain. J Orthop Sci. 2013;18(1):130-6. doi: 10.1007/s00776-012-0302-0. [PubMed: 22996813]. [PubMed Central: PMC3553403].
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments